48 related articles for article (PubMed ID: 24453125)
1. Transcriptional profiling of recall responses to Francisella live vaccine strain.
Paranavitana C; DaSilva L; Vladimirova A; Pittman PR; Velauthapillai M; Nikolich M
Pathog Dis; 2014 Mar; 70(2):141-52. PubMed ID: 24453125
[TBL] [Abstract][Full Text] [Related]
2. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria.
Ben Nasr A; Haithcoat J; Masterson JE; Gunn JS; Eaves-Pyles T; Klimpel GR
J Leukoc Biol; 2006 Oct; 80(4):774-86. PubMed ID: 16857732
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional profiling of Francisella tularensis infected peripheral blood mononuclear cells: a predictive tool for tularemia.
Paranavitana C; Pittman PR; Velauthapillai M; Zelazowska E; Dasilva L
FEMS Immunol Med Microbiol; 2008 Oct; 54(1):92-103. PubMed ID: 18680519
[TBL] [Abstract][Full Text] [Related]
4. Th17 cytokines in recall responses against Francisella tularensis in humans.
Paranavitana C; Zelazowska E; DaSilva L; Pittman PR; Nikolich M
J Interferon Cytokine Res; 2010 Jul; 30(7):471-6. PubMed ID: 20626289
[TBL] [Abstract][Full Text] [Related]
5. Natural killer and CD8 T cells dominate the response by human peripheral blood mononuclear cells to inactivated Francisella tularensis live vaccine strain.
Gosselin EJ; Gosselin DR; Lotz SA
Hum Immunol; 2005 Oct; 66(10):1039-49. PubMed ID: 16386645
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination.
Fuller CL; Brittingham KC; Porter MW; Hepburn MJ; Petitt PL; Pittman PR; Bavari S
Mol Immunol; 2007 May; 44(12):3173-84. PubMed ID: 17349694
[TBL] [Abstract][Full Text] [Related]
7. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
Cowley SC; Meierovics AI; Frelinger JA; Iwakura Y; Elkins KL
J Immunol; 2010 May; 184(10):5791-801. PubMed ID: 20393138
[TBL] [Abstract][Full Text] [Related]
8. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W
Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853
[TBL] [Abstract][Full Text] [Related]
9. Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells.
Telepnev M; Golovliov I; Sjöstedt A
Microb Pathog; 2005; 38(5-6):239-47. PubMed ID: 15925273
[TBL] [Abstract][Full Text] [Related]
10. Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia.
Hepburn MJ; Purcell BK; Lawler JV; Coyne SR; Petitt PL; Sellers KD; Norwood DA; Ulrich MP
Clin Infect Dis; 2006 Sep; 43(6):711-6. PubMed ID: 16912944
[TBL] [Abstract][Full Text] [Related]
11. Temporal cytokine profiling of Francisella tularensis-infected human peripheral blood mononuclear cells.
Paranavitana C; Pittman P; Velauthapillai M; DaSilva L
J Microbiol Immunol Infect; 2008 Jun; 41(3):192-9. PubMed ID: 18629413
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis.
Waag DM; McKee KT; Sandstrom G; Pratt LL; Bolt CR; England MJ; Nelson GO; Williams JC
Clin Diagn Lab Immunol; 1995 Mar; 2(2):143-8. PubMed ID: 7697521
[TBL] [Abstract][Full Text] [Related]
13. Vaccination strategies for Francisella tularensis.
Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
[TBL] [Abstract][Full Text] [Related]
14. Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS).
Eyles JE; Hartley MG; Laws TR; Oyston PC; Griffin KF; Titball RW
Microb Pathog; 2008 Feb; 44(2):164-8. PubMed ID: 17904793
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
Green M; Choules G; Rogers D; Titball RW
Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
[TBL] [Abstract][Full Text] [Related]
16. Francisella tularensis vaccines.
Griffin KF; Oyston PC; Titball RW
FEMS Immunol Med Microbiol; 2007 Apr; 49(3):315-23. PubMed ID: 17316369
[TBL] [Abstract][Full Text] [Related]
17. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism.
Anthony LS; Morrissey PJ; Nano FE
J Immunol; 1992 Mar; 148(6):1829-34. PubMed ID: 1541823
[TBL] [Abstract][Full Text] [Related]
19. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.
Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S
J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351
[No Abstract] [Full Text] [Related]
20. Nature of protective immunity to Francisella tularensis.
Tärnvik A
Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
